Results 1 to 4 of about 4 (4)

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. [PDF]

Pharmacoeconomics, 2023
Wijnen B, Witlox W, Wolff R, Fayter D, Ramaekers B, Otten T, Ryder S, Posadzki P, Worthy G, Stirk L, Armstrong N, Kleijnen J, Joore M.   +12 more
europepmc   +1 more source

Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy. [PDF]

PLoS One, 2015
Lin KY, Liao SH, Liu WC, Cheng A, Lin SW, Chang SY, Tsai MS, Kuo CH, Wu MR, Wang HP, Hung CC, Chang SC.   +11 more
europepmc   +1 more source

Approaches used to model patient and carer health-related quality of life in economic models of rare disease treatments in NICE appraisals. [PDF]

Health Qual Life Outcomes
Wiedmann L, Cairns J.
europepmc   +1 more source

Carer Health-Related Quality of Life: A Review of Modelling Considerations in National Institute for Health and Care Excellence Technology Appraisals (2000-2023). [PDF]

Pharmacoecon Open
Ahmadu C, Evers E, Lister J, Liu FX, Darlington O.   +4 more
europepmc   +1 more source